Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

United States — ClinicalTrials.gov

Tracked across 3 events · 18 articles · First seen May 26, 2026 · Last active Aug 21, 2026

Sentiment
0
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 0
Regulatory
A study published in PLOS on August 19, 2026, analyzed all 1,357 AI-based medical devices authorized by the U.S. United States — Food and Drug Administration (FDA) as of December 5, 2025. The researchers, led…
Impact: The registry was used to identify trials; the study highlights the low number of registered trials for AI devices.
Aug 19, 2026 · 6 articles
2 0
Business
Impact: United States — ClinicalTrials.gov is a source of information for the AimwellBio Observer network, providing source-traced signals.
Jun 29, 2026 · 6 articles
2 0
Tech
Impact: The study was registered on United States — ClinicalTrials.gov>>>, ensuring transparency and adherence to research standards.
May 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Track United States — ClinicalTrials.gov live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.